ArticleAnnals of vascular diseases2026
Complete Modular Disconnection between AFX2 and VELA Leading to a Type IIIa Endoleak Two Years after Endovascular Aneurysm Repair.
Article in Annals of vascular diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The AFX endograft (Endologix, Irvine, CA, USA) is known to have a high incidence of late type III endoleaks. We report a 76-year-old male who developed a type IIIa endoleak due to complete modular separation 2 years after endovascular aneurysm repair with an AFX2 main body and a VELA extension. Open surgical graft replacement was performed, and the postoperative course was uneventful. This case demonstrates that in the presence of a large aneurysm diameter or significant neck angulation, even Instructions for Use-compliant and recommended overlap may be insufficient. It suggests the necessity of securing greater overlap and implementing stricter follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.